337 related articles for article (PubMed ID: 25305755)
1. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors.
Zhang M; Wang Y; Jones S; Sausen M; McMahon K; Sharma R; Wang Q; Belzberg AJ; Chaichana K; Gallia GL; Gokaslan ZL; Riggins GJ; Wolinksy JP; Wood LD; Montgomery EA; Hruban RH; Kinzler KW; Papadopoulos N; Vogelstein B; Bettegowda C
Nat Genet; 2014 Nov; 46(11):1170-2. PubMed ID: 25305755
[TBL] [Abstract][Full Text] [Related]
2. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.
Sohier P; Luscan A; Lloyd A; Ashelford K; Laurendeau I; Briand-Suleau A; Vidaud D; Ortonne N; Pasmant E; Upadhyaya M
Genes Chromosomes Cancer; 2017 May; 56(5):421-426. PubMed ID: 28124441
[TBL] [Abstract][Full Text] [Related]
4. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
Cleven AH; Sannaa GA; Briaire-de Bruijn I; Ingram DR; van de Rijn M; Rubin BP; de Vries MW; Watson KL; Torres KE; Wang WL; van Duinen SG; Hogendoorn PC; Lazar AJ; Bovée JV
Mod Pathol; 2016 Jun; 29(6):582-90. PubMed ID: 26990975
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
[TBL] [Abstract][Full Text] [Related]
6. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
Zhang X; Murray B; Mo G; Shern JF
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
[TBL] [Abstract][Full Text] [Related]
7. PRC2 loss amplifies Ras signaling in cancer.
Baude A; Lindroth AM; Plass C
Nat Genet; 2014 Nov; 46(11):1154-5. PubMed ID: 25352098
[TBL] [Abstract][Full Text] [Related]
8. [PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex].
Luscan A; Vidaud D; Ortonne N; Wolkenstein P; Vidaud M; Pasmant E
Med Sci (Paris); 2014; 30(8-9):733-5. PubMed ID: 25174745
[No Abstract] [Full Text] [Related]
9. EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.
Zhang P; Garnett J; Creighton CJ; Al Sannaa GA; Igram DR; Lazar A; Liu X; Liu C; Pollock RE
J Pathol; 2014 Feb; 232(3):308-18. PubMed ID: 24132643
[TBL] [Abstract][Full Text] [Related]
10. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.
Le Guellec S; Macagno N; Velasco V; Lamant L; Lae M; Filleron T; Malissen N; Cassagnau E; Terrier P; Chevreau C; Ranchere-Vince D; Coindre JM
Mod Pathol; 2017 Dec; 30(12):1677-1687. PubMed ID: 28752843
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.
Dubbink HJ; Bakels H; Post E; Zwarthoff EC; Verdijk RM
J Neurooncol; 2014 Nov; 120(2):267-72. PubMed ID: 25035100
[TBL] [Abstract][Full Text] [Related]
12. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
Prieto-Granada CN; Wiesner T; Messina JL; Jungbluth AA; Chi P; Antonescu CR
Am J Surg Pathol; 2016 Apr; 40(4):479-89. PubMed ID: 26645727
[TBL] [Abstract][Full Text] [Related]
13. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
[TBL] [Abstract][Full Text] [Related]
14. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
[TBL] [Abstract][Full Text] [Related]
15. Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors.
Schaefer IM; Dong F; Garcia EP; Fletcher CDM; Jo VY
Am J Surg Pathol; 2019 Jun; 43(6):835-843. PubMed ID: 30864974
[TBL] [Abstract][Full Text] [Related]
16. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
Korfhage J; Lombard DB
Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.
Staedtke V; Bai RY; Blakeley JO
Neurotherapeutics; 2017 Apr; 14(2):298-306. PubMed ID: 28349408
[TBL] [Abstract][Full Text] [Related]
18. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
[TBL] [Abstract][Full Text] [Related]
19.
Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
[TBL] [Abstract][Full Text] [Related]
20. MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression.
Wallander ML; Tripp S; Layfield LJ
Arch Pathol Lab Med; 2012 Jan; 136(1):95-9. PubMed ID: 22208493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
